Neuroprotective Mechanisms of Ficus deltoidea in an Alzheimer’s Disease-Like Rat Model: Targeting Tau Hyperphosphorylation Through Glycogen Synthase Kinase-3 Beta and Protein Phosphatase 2A Regulation

No abstract is available for this paper.

• Publication year

  2026

• Venue

  Neurochemical Research

• Publication date

  2026-02-20

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1007/s11064-026-04702-0PMID 41718891PMCID PMC12923462
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting of PP2 A/GSK3β/PTEN Axis in Alzheimer Disease: The Mooting Evidence, Divine, and Devil

  2025cited by this paper
• Natural products against tau hyperphosphorylation‐induced aggregates: Potential therapies for Alzheimer's disease

  2025cited by this paper
• Natural compounds from herbs and nutraceuticals as glycogen synthase kinase‐3β inhibitors in Alzheimer's disease treatment

  2024cited by this paper
• Molecular Role of Protein Phosphatases in Alzheimer’s and Other Neurodegenerative Diseases

  2024cited by this paper
• Structures of AT8 and PHF1 phosphomimetic tau: Insights into the posttranslational modification code of tau aggregation

  2024cited by this paper
• Delta-9-tetrahydrocannabinol Ameliorates D-galactose/ Aluminium Chloride-Induced Alzheimer’s-Like Cognitive Deficit in Rats via Neurogenesis in their Hippocampus

  2024cited by this paper
• Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History

  2024cited by this paper
• Could protein phosphatase 2A and glycogen synthase kinase-3 beta be targeted by natural compounds to ameliorate Alzheimer's pathologies?

  2024cited by this paper
• Osmundacetone ameliorates Alzheimer's-like pathologies by inhibiting β-amyloid fibrillation, oxidative damage and neuroinflammation in APP/PS1 transgenic mice.

  2024cited by this paper
• Sulforaphene, a CDK5 Inhibitor, attenuates cognitive deficits in a transgenic mouse model of Alzheimer's disease via reducing Aβ Deposition, tau hyperphosphorylation and synaptic dysfunction.

  2023cited by this paper
• TREM2 Inhibits Tau Hyperphosphorylation and Neuronal Apoptosis via the PI3K/Akt/GSK-3β Signaling Pathway In vivo and In vitro

  2023cited by this paper
• Targeting Abnormal Tau Phosphorylation for Alzheimer’s Therapeutics

  2023cited by this paper
• Empagliflozin targets Mfn1 and Opa1 to attenuate microglia-mediated neuroinflammation in retinal ischemia and reperfusion injury

  2023cited by this paper
• TREATMENT OF ALZHEIMER’S DISEASE: AN INTEGRATIVE REVIEW ON THE EFFECTIVENESS OF CHOLINESTERASE AND MEMANTINE INHIBITORS

  2023cited by this paper
• Elderly and their companion animals, cause for pleasure or for harm, a case report of a non-bite Pasteurella multocida bacteremia in an 85-year-old woman with a fatal outcome

  2023cited by this paper
• Alzheimer's disease: 120 years of research and progress

  2023cited by this paper
• Corrigendum: Type 2 diabetes increases risk of unfavorable survival outcome for postoperative ischemic stroke in patients who underwent non-cardiac surgery: A retrospective cohort study

  2023cited by this paper
• Naringin Protects against Tau Hyperphosphorylation in Aβ25–35-Injured PC12 Cells through Modulation of ER, PI3K/AKT, and GSK-3β Signaling Pathways

  2023cited by this paper
• The Quest for Neurodegenerative Disease Treatment—Focusing on Alzheimer’s Disease Personalised Diets

  2023cited by this paper
• Alzheimer’s disease: Ablating single master site abolishes tau hyperphosphorylation

  2022cited by this paper
• Insights into the Pathophysiology of Alzheimer’s Disease and Potential Therapeutic Targets: A Current Perspective

  2022cited by this paper
• Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies

  2022cited by this paper
• Neuroprotective effect of naringin against cerebellar changes in Alzheimer’s disease through modulation of autophagy, oxidative stress and tau expression: An experimental study

  2022cited by this paper
• Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2019

  2022cited by this paper
• Controversial Effects of Diverse Types of Toxoplasma gondii on the Anxiety-Related Behavior and Cognitive Impairments in the Animal Model of Alzheimer's Disease

  2022cited by this paper
• RETRACTED ARTICLE: Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling

  2022cited by this paper
• Neural Mechanisms of Motor Dysfunction in Mild Cognitive Impairment and Alzheimer’s Disease: A Systematic Review

  2022cited by this paper
• Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives

  2022cited by this paper
• Locomotor Adaptation Deficits in Older Individuals With Cognitive Impairments: A Pilot Study

  2022cited by this paper
• Dementia of the Ageing Population in Malaysia: A Scoping Review of Published Research

  2022cited by this paper
• miR-23b-3p rescues cognition in Alzheimer’s disease by reducing tau phosphorylation and apoptosis via GSK-3β signaling pathways

  2022cited by this paper
• Neuroprotective Effects of Green Tea Seed Isolated Saponin Due to the Amelioration of Tauopathy and Alleviation of Neuroinflammation: A Therapeutic Approach to Alzheimer’s Disease

  2022cited by this paper
• Personalized treatment interventions: nonpharmacological and natural treatment strategies in Alzheimer’s disease

  2021cited by this paper
• Mechanism by Which Aluminum Regulates the Abnormal Phosphorylation of the Tau Protein in Different Cell Lines

  2021cited by this paper
• The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

  2021cited by this paper
• WIN55,212-2 Attenuates Cognitive Impairments in AlCl3 + d-Galactose-Induced Alzheimer’s Disease Rats by Enhancing Neurogenesis and Reversing Oxidative Stress

  2021cited by this paper
• Pathological mechanisms and therapeutic strategies for Alzheimer’s disease

  2021cited by this paper
• Role of Natural Products for the Treatment of Alzheimer's Disease.

  2021cited by this paper
• Ficus deltoidea: Potential Inhibitor of Pro-Inflammatory Mediators in Lipopolysaccharide-Induced Activation of Microglial Cells.

  2021cited by this paper
• The Role of Amyloid-Beta and Tau in the Early Pathogenesis of Alzheimer’s Disease

  2021cited by this paper
• Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021

  2021cited by this paper
• Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease

  2021cited by this paper
• GSK-3 and Tau: A Key Duet in Alzheimer’s Disease

  2021cited by this paper
• Lead acetate-induced neurodegenerative changes in the dorsolateral prefrontal cortex of mice: the role of Vitexin

  2020cited by this paper
• Naringenin protects AlCl3/D-galactose induced neurotoxicity in rat model of AD via attenuation of acetylcholinesterase levels and inhibition of oxidative stress

  2020influential reference
• Glycogen synthase kinase-3 signaling in Alzheimer's disease.

  2020cited by this paper
• Protein Phosphatase 2A as a Drug Target in the Treatment of Cancer and Alzheimer’s Disease

  2020cited by this paper
• Exploring the multimodal role of phytochemicals in the modulation of cellular signaling pathways to combat age-related neurodegeneration.

  2020cited by this paper
• Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer’s disease models

  2020cited by this paper
• Memantine, Donepezil, or Combination Therapy—What is the best therapy for Alzheimer’s Disease? A Network Meta‐Analysis

  2020cited by this paper
• Centella asiatica prevents D-galactose-Induced cognitive deficits, oxidative stress and neurodegeneration in the adult rat brain

  2020cited by this paper
• Fungal Shaker-like channels beyond cellular K+ homeostasis: A role in ectomycorrhizal symbiosis between Hebeloma cylindrosporum and Pinus pinaster

  2020cited by this paper
• Permethrin exposure affects neurobehavior and cellular characterization in rats’ brain

  2020cited by this paper
• Centella asiatica Protects d-Galactose/AlCl3 Mediated Alzheimer’s Disease-Like Rats via PP2A/GSK-3β Signaling Pathway in Their Hippocampus

  2019cited by this paper
• Voluntary, involuntary and forced exercises almost equally reverse behavioral impairment by regulating hippocampal neurotrophic factors and oxidative stress in experimental Alzheimer's disease model

  2019cited by this paper
• Targeting Inflammatory Pathways in Alzheimer’s Disease: A Focus on Natural Products and Phytomedicines

  2019cited by this paper
• Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics

  2019cited by this paper
• Protective effect of Centella asiatica against D-galactose and aluminium chloride induced rats: Behavioral and ultrastructural approaches.

  2019cited by this paper
• The modulatory role of phloretin in Aβ25–35 induced sporadic Alzheimer’s disease in rat model

  2018cited by this paper
• Modulating Protein Phosphatase 2A Rescues Disease Phenotype in Neurodegenerative Tauopathies.

  2018cited by this paper
• Experimental and computational approaches to reveal the potential of Ficus deltoidea leaves extract as α-amylase inhibitor

  2018cited by this paper
• A role of Ficus species in the management of diabetes mellitus: A review.

  2018cited by this paper
• d-galactose and aluminium chloride induced rat model with cognitive impairments.

  2018influential reference
• A Brief Review on the Neuroprotective Mechanisms of Vitexin

  2018cited by this paper
• Improvement of spatial learning and memory, cortical gyrification patterns and brain oxidative stress markers in diabetic rats treated with Ficus deltoidea leaf extract and vitexin

  2017cited by this paper
• In Vitro Pro-apoptotic and Anti-migratory Effects of Ficus deltoidea L. Plant Extracts on the Human Prostate Cancer Cell Lines PC3

  2017cited by this paper
• Role of GSK3 β and PP2A on Regulation of Tau Phosphorylation in Hippocampus and Memory Impairment in ICV-STZ Animal Model of Alzheimer’s Disease

  2017cited by this paper
• Downregulation of protein phosphatase 2A by apolipoprotein E: Implications for Alzheimer's disease

  2017cited by this paper
• Ginsenoside Rb1 ameliorates cisplatin-induced learning and memory impairments

  2017cited by this paper
• Molecular Pathogenesis of Alzheimer's Disease: An Update

  2017cited by this paper
• Astroglia dynamics in ageing and Alzheimer's disease.

  2016cited by this paper
• Prostate cancer cell inhibition by ethanolic fraction of Ficus deltoidea var. kunstleri

  2016cited by this paper
• Drug treatments in Alzheimer's disease.

  2016cited by this paper
• Ferulic acid ameliorates memory impairment in d-galactose-induced aging mouse model

  2016cited by this paper
• AN in vitro STUDY OF WOUND HEALING ACTIVITY OF Ficus deltoidea LEAF EXTRACT

  2015cited by this paper
• Zinc binds to and directly inhibits protein phosphatase 2A in vitro

  2015cited by this paper
• Phytochemical Constituents in Leaves and Callus of Ficus deltoidea Jack var. Kunstleri (King) Corner

  2014cited by this paper
• Ficus deltoidea Jack: A Review on Its Phytochemical and Pharmacological Importance

  2014cited by this paper
• Phytochemical, Pharmacological and Toxicological Properties ofFicusdeltoidea:A Review of a Recent Research

  2014cited by this paper
• Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer’s Disease: Understanding the Therapeutics Strategies

  2014cited by this paper
• Genotoxicity and acute and subchronic toxicity studies of a standardized methanolic extract of Ficus deltoidea leaves

  2013cited by this paper
• Tau protein phosphatases in Alzheimer's disease: the leading role of PP2A.

  2013cited by this paper
• Inhibition of Free Radical and Neuroprotective Effect of Four Varieties of Ficus deltoidea

  2012influential reference
• Roles of glycogen synthase kinase 3 in Alzheimer's disease.

  2012cited by this paper
• Protein phosphatases and Alzheimer's disease.

  2012cited by this paper
• Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type.

  2012cited by this paper
• New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.

  2012cited by this paper
• Vitexin and isovitexin from the Leaves of Ficus deltoidea with in-vivo α-glucosidase inhibition.

  2012cited by this paper
• Anti-Inflammatory Activity of the Aqueous Extract of Ficus Deltoidea

  2012cited by this paper
• Ficus deltoidea: A Potential Alternative Medicine for Diabetes Mellitus

  2012cited by this paper
• Antioxidant effects of the orientin and vitexin in Trollius chinensis Bunge in D-galactose-aged mice

  2012cited by this paper
• Production of flavonoid compounds in cell cultures of Ficus deltoidea as influenced by medium composition.

  2011cited by this paper
• The role of hippocampal subregions in memory for stimulus associations.

  2010cited by this paper
• Evaluation of the antinociceptive activity of Ficus deltoidea aqueous extract.

  2008cited by this paper
• Effects of Ficus deltoidea aqueous extract on hematological and biochemical parameters in rats.

  2008cited by this paper
• 7-Nitroindazole, a neuronal nitric oxide synthase inhibitor, impairs passive-avoidance and elevated plus-maze memory performance in rats.

  2007cited by this paper
• The dentate gyrus: fundamental neuroanatomical organization (dentate gyrus for dummies).

  2007cited by this paper
• Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock

  1990cited by this paper
• Anatomy of the Hippocampus

  1988cited by this paper

• No citing papers are available for this paper.